Interaction of glucocorticoids with FXR/FGF19/FGF21-mediated ileum-liver crosstalk

Biochimica et Biophysica Acta - Molecular Basis of Disease

Volumn 1864, Issue 9, 2018, Pages 2927-2937

  Al Aqil, Faten A ^a   Monte, Maria J ^a,d   Peleteiro Vigil, Ana ^a   Briz, Oscar ^a,d   Rosales, Ruben ^a   González, Raquel ^b,d   Aranda, Carlos J ^b   Ocón, Borja ^b   Uriarte, Iker ^c,d   de Medina, Fermín Sánchez ^b,d   Martinez Augustín, Olga ^b,d   Avila, Matías A ^c,d   Marín, José J G ^a,d   Romero, Marta R ^a,d  

^a UNIVERSITY OF SALAMANCA   (Spain)

^b UNIVERSITY OF GRANADA   (Spain)

^c UNIVERSITY OF NAVARRA   (Spain)

^d INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

Cholestasis; Gene regulation; Intestine; Metabolism; Transport

Indexed keywords

BUDESONIDE; CHOLESTEROL 7ALPHA MONOOXYGENASE; CYTOCHROME P450; CYTOCHROME P450 3A11; CYTOCHROME P450 4A14; DEXAMETHASONE; FARNESOID X RECEPTOR; FIBROBLAST GROWTH FACTOR 19; FIBROBLAST GROWTH FACTOR 21; GLUCOCORTICOID; MESSENGER RNA; PREDNISOLONE; PROTEIN; UNCLASSIFIED DRUG; VANIN 1; BILE ACID; CELL RECEPTOR; CHOLESTEROL; FARNESOID X-ACTIVATED RECEPTOR; FGF19 PROTEIN, HUMAN; FGF19 PROTEIN, RAT; FIBROBLAST GROWTH FACTOR; FIBROBLAST GROWTH FACTOR 15, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; DRUG MEGADOSE; EXPERIMENTAL COLITIS; GENE EXPRESSION; HEP-G2 CELL LINE; HUMAN; HUMAN CELL; ILEUM; LIVER; LIVER TOXICITY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN PHOSPHORYLATION; RAT; UPREGULATION; ANIMAL; AUTOCRINE EFFECT; BIOSYNTHESIS; C57BL MOUSE; CHEMICALLY INDUCED; COLITIS; DISEASE MODEL; DRUG EFFECT; FEMALE; GENETICS; KNOCKOUT MOUSE; METABOLISM; PATHOLOGY; SIGNAL TRANSDUCTION; WISTAR RAT;

ANIMALS; AUTOCRINE COMMUNICATION; BILE ACIDS AND SALTS; CHOLESTEROL; CHOLESTEROL 7-ALPHA-HYDROXYLASE; COLITIS; DISEASE MODELS, ANIMAL; FEMALE; FIBROBLAST GROWTH FACTORS; GLUCOCORTICOIDS; HEP G2 CELLS; HUMANS; ILEUM; LIVER; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; RATS; RATS, WISTAR; RECEPTORS, CYTOPLASMIC AND NUCLEAR; SIGNAL TRANSDUCTION; UP-REGULATION;

EID: 85048345788     PISSN: 09254439     EISSN: 1879260X     Source Type: Journal    
DOI: 10.1016/j.bbadis.2018.06.003     Document Type: Article

References (52)

1. Rosales, R., Romero, M.R., Vaquero, J., Monte, M.J., Requena, P., Martinez-Augustin, O., Sanchez De Medina, F., Marin, J.J., FXR-dependent and -independent interaction of glucocorticoids with the regulatory pathways involved in the control of bile acid handling by the liver. Biochem. Pharmacol. 85 (2013), 829–838.
2. Marin, J.J., Macias, R.I., Briz, O., Banales, J.M., Monte, M.J., Bile acids in physiology, pathology and pharmacology. Curr. Drug Metab. 17 (2015), 4–29.
3. Lu, Y., Zhang, Z., Xiong, X., Wang, X., Li, J., Shi, G., Yang, J., Zhang, X., Zhang, H., Hong, J., Xia, X., Ning, G., Li, X., Glucocorticoids promote hepatic cholestasis in mice by inhibiting the transcriptional activity of the farnesoid X receptor. Gastroenterology 143 (2012), 1630–1640 (e1638).
4. Out, C., Dikkers, A., Laskewitz, A., Boverhof, R., van der Ley, C., Kema, I.P., Wolters, H., Havinga, R., Verkade, H.J., Kuipers, F., Tietge, U.J., Groen, A.K., Prednisolone increases enterohepatic cycling of bile acids by induction of Asbt and promotes reverse cholesterol transport. J. Hepatol. 61 (2014), 351–357.
5. van der Geest, R., Ouweneel, A.B., van der Sluis, R.J., Groen, A.K., Van Eck, M., Hoekstra, M., Endogenous glucocorticoids exacerbate cholestasis-associated liver injury and hypercholesterolemia in mice. Toxicol. Appl. Pharmacol. 306 (2016), 1–7.
6. Vispute, S.G., Bu, P., Le, Y., Cheng, X., Activation of GR but not PXR by dexamethasone attenuated acetaminophen hepatotoxicities via Fgf21 induction. Toxicology 378 (2017), 95–106.
7. Li, R., Guo, C., Wu, X., Huang, Z., Chen, J., FGF21 functions as a sensitive biomarker of APAP-treated patients and mice. Oncotarget 80 (2017), 44440–44446.
8. Kir, S., Beddow, S.A., Samuel, V.T., Miller, P., Previs, S.F., Suino-Powell, K., Xu, H.E., Shulman, G.I., Kliewer, S.A., Mangelsdorf, D.J., FGF19 as a postprandial, insulin-independent activator of hepatic protein and glycogen synthesis. Science 331 (2011), 1621–1624.
9. Potthoff, M.J., Inagaki, T., Satapati, S., Ding, X., He, T., Goetz, R., Mohammadi, M., Finck, B.N., Mangelsdorf, D.J., Kliewer, S.A., Burgess, S.C., FGF21 induces PGC-1alpha and regulates carbohydrate and fatty acid metabolism during the adaptive starvation response. Proc. Natl. Acad. Sci. U. S. A. 106 (2009), 10853–10858.
10. Uriarte, I., Fernandez-Barrena, M.G., Monte, M.J., Latasa, M.U., Chang, H.C., Carotti, S., Vespasiani-Gentilucci, U., Morini, S., Vicente, E., Concepcion, A.R., Medina, J.F., Marin, J.J., Berasain, C., Prieto, J., Avila, M.A., Identification of fibroblast growth factor 15 as a novel mediator of liver regeneration and its application in the prevention of post-resection liver failure in mice. Gut 62 (2013), 899–910.
11. el Marjou, F., Janssen, K.P., Chang, B.H., Li, M., Hindie, V., Chan, L., Louvard, D., Chambon, P., Metzger, D., Robine, S., Tissue-specific and inducible Cre-mediated recombination in the gut epithelium. Genesis 39 (2004), 186–193.
12. Ocon, B., Aranda, C.J., Gamez-Belmonte, R., Suarez, M.D., Zarzuelo, A., Martinez-Augustin, O., Sanchez de Medina, F., The glucocorticoid budesonide has protective and deleterious effects in experimental colitis in mice. Biochem. Pharmacol. 116 (2016), 73–88.
13. Laible, M., Boonrod, K., Homemade site directed mutagenesis of whole plasmids. J. Vis. Exp., 11(27), 2009, 10.3791/1135.
14. Vaquero, J., Monte, M.J., Dominguez, M., Muntane, J., Marin, J.J., Differential activation of the human farnesoid X receptor depends on the pattern of expressed isoforms and the bile acid pool composition. Biochem. Pharmacol. 86 (2013), 926–939.
15. Tanic, N., Perovic, M., Mladenovic, A., Ruzdijic, S., Kanazir, S., Effects of aging, dietary restriction and glucocorticoid treatment on housekeeping gene expression in rat cortex and hippocampus-evaluation by real time RT-PCR. J. Mol. Neurosci. 32 (2007), 38–46.
16. Beekman, L., Tohver, T., Dardari, R., Leguillette, R., Evaluation of suitable reference genes for gene expression studies in bronchoalveolar lavage cells from horses with inflammatory airway disease. BMC Mol. Biol., 12, 2011, 5.
17. Monte, M.J., Martinez-Diez, M.C., El-Mir, M.Y., Mendoza, M.E., Bravo, P., Bachs, O., Marin, J.J., Changes in the pool of bile acids in hepatocyte nuclei during rat liver regeneration. J. Hepatol. 36 (2002), 534–542.
18. Nytofte, N.S., Serrano, M.A., Monte, M.J., Gonzalez-Sanchez, E., Tumer, Z., Ladefoged, K., Briz, O., Marin, J.J., A homozygous nonsense mutation (c.214C->A) in the biliverdin reductase alpha gene (BLVRA) results in accumulation of biliverdin during episodes of cholestasis. J. Med. Genet. 48 (2011), 219–225.
19. Ye, L., Liu, S., Wang, M., Shao, Y., Ding, M., High-performance liquid chromatography-tandem mass spectrometry for the analysis of bile acid profiles in serum of women with intrahepatic cholestasis of pregnancy. J. Chromatogr. B Anal. Technol. Biomed. Life Sci. 860 (2007), 10–17.
20. Lenilek, M., Vecka, M., Zizalova, K., Vitek, L., Comparison of simple extraction procedures in liquid chromatography-mass spectrometry based determination of serum 7alpha-hydroxy-4-cholesten-3-one, a surrogate marker of bile acid synthesis. J. Chromatogr. B Anal. Technol. Biomed. Life Sci. 1033–1034 (2016), 317–320.
21. Steiner, C., von Eckardstein, A., Rentsch, K.M., Quantification of the 15 major human bile acids and their precursor 7alpha-hydroxy-4-cholesten-3-one in serum by liquid chromatography-tandem mass spectrometry. J. Chromatogr. B Anal. Technol. Biomed. Life Sci. 878 (2010), 2870–2880.
22. Micuda, S., Fuksa, L., Mundlova, L., Osterreicher, J., Mokry, J., Cermanova, J., Brcakova, E., Staud, F., Pokorna, P., Martinkova, J., Morphological and functional changes in p-glycoprotein during dexamethasone-induced hepatomegaly. Clin. Exp. Pharmacol. Physiol. 34 (2007), 296–303.
23. Merrell, M.D., Nyagode, B.A., Clarke, J.D., Cherrington, N.J., Morgan, E.T., Selective and cytokine-dependent regulation of hepatic transporters and bile acid homeostasis during infectious colitis in mice. Drug Metab. Dispos. 42 (2014), 596–602.
24. Rau, M., Stieger, B., Monte, M.J., Schmitt, J., Jahn, D., Frey-Wagner, I., Raselli, T., Marin, J.J., Mullhaupt, B., Rogler, G., Geier, A., Alterations in enterohepatic Fgf15 signaling and changes in bile acid composition depend on localization of murine intestinal inflammation. Inflamm. Bowel Dis. 22 (2016), 2382–2389.
25. Vaquero, J., Briz, O., Herraez, E., Muntane, J., Marin, J.J., Activation of the nuclear receptor FXR enhances hepatocyte chemoprotection and liver tumor chemoresistance against genotoxic compounds. Biochim. Biophys. Acta 1833 (2013), 2212–2219.
26. Ramakrishna, R., Kumar, D., Bhateria, M., Gaikwad, A.N., Bhatta, R.S., 16-Dehydropregnenolone lowers serum cholesterol by up-regulation of CYP7A1 in hyperlipidemic male hamsters. J. Steroid Biochem. Mol. Biol. 168 (2017), 110–117.
27. Ge, X., Chen, C., Hui, X., Wang, Y., Lam, K.S., Xu, A., Fibroblast growth factor 21 induces glucose transporter-1 expression through activation of the serum response factor/Ets-like protein-1 in adipocytes. J. Biol. Chem. 286 (2011), 34533–34541.
28. Cyphert, H.A., Ge, X., Kohan, A.B., Salati, L.M., Zhang, Y., Hillgartner, F.B., Activation of the farnesoid X receptor induces hepatic expression and secretion of fibroblast growth factor 21. J. Biol. Chem. 287 (2012), 25123–25138.
29. Sherratt, A.J., Banet, D.E., Linder, M.W., Prough, R.A., Potentiation of 3-methylcholanthrene induction of rat hepatic cytochrome P450IA1 by dexamethasone in vivo. J. Pharmacol. Exp. Ther. 249 (1989), 667–672.
30. Zhao, L.Y., Xu, J.Y., Shi, Z., Englert, N.A., Zhang, S.Y., Pregnane X receptor (PXR) deficiency improves high fat diet-induced obesity via induction of fibroblast growth factor 15 (FGF15) expression. Biochem. Pharmacol. 142 (2017), 194–203.
31. Down, M.J., Arkle, S., Mills, J.J., Regulation and induction of CYP3A11, CYP3A13 and CYP3A25 in C57BL/6J mouse liver. Arch. Biochem. Biophys. 457 (2007), 105–110.
32. Heuman, D.M., Gallagher, E.J., Barwick, J.L., Elshourbagy, N.A., Guzelian, P.S., Immunochemical evidence for induction of a common form of hepatic cytochrome P-450 in rats treated with pregnenolone-16 alpha-carbonitrile or other steroidal or non-steroidal agents. Mol. Pharmacol. 21 (1982), 753–760.
33. Xie, W., Barwick, J.L., Downes, M., Blumberg, B., Simon, C.M., Nelson, M.C., Neuschwander-Tetri, B.A., Brunt, E.M., Guzelian, P.S., Evans, R.M., Humanized xenobiotic response in mice expressing nuclear receptor SXR. Nature 406 (2000), 435–439.
34. Xu, D.X., Wang, J.P., Sun, M.F., Chen, Y.H., Wei, W., Lipopolysaccharide downregulates the expressions of intestinal pregnane X receptor and cytochrome P450 3a11. Eur. J. Pharmacol. 536 (2006), 162–170.
35. Staudinger, J.L., Goodwin, B., Jones, S.A., Hawkins-Brown, D., MacKenzie, K.I., Latour, A., Liu, Y., Klaassen, C.D., Brown, K.K., Reinhard, J., Willson, T.M., Koller, B.H., Kliewer, S.A., The nuclear receptor PXR is a lithocholic acid sensor that protects against liver toxicity. Proc. Natl. Acad. Sci. U. S. A. 98 (2001), 3369–3374.
36. Yamasaki, Y., Kobayashi, K., Inaba, A., Uehara, D., Tojima, H., Kakizaki, S., Chiba, K., Indirect activation of pregnane X receptor in the induction of hepatic CYP3A11 by high-dose rifampicin in mice. Xenobiotica, 2017, 1–8.
37. Chiang, J.Y., Kimmel, R., Stroup, D., Regulation of cholesterol 7alpha-hydroxylase gene (CYP7A1) transcription by the liver orphan receptor (LXRalpha). Gene 262 (2001), 257–265.
38. Ando, H., Tsuruoka, S., Yamamoto, H., Takamura, T., Kaneko, S., Fujimura, A., Regulation of cholesterol 7alpha-hydroxylase mRNA expression in C57BL/6 mice fed an atherogenic diet. Atherosclerosis 178 (2005), 265–269.
39. Uebanso, T., Taketani, Y., Yamamoto, H., Amo, K., Tanaka, S., Arai, H., Takei, Y., Masuda, M., Yamanaka-Okumura, H., Takeda, E., Liver X receptor negatively regulates fibroblast growth factor 21 in the fatty liver induced by cholesterol-enriched diet. J. Nutr. Biochem. 23 (2012), 785–790.
40. Archer, A., Venteclef, N., Mode, A., Pedrelli, M., Gabbi, C., Clement, K., Parini, P., Gustafsson, J.A., Korach-Andre, M., Fasting-induced FGF21 is repressed by LXR activation via recruitment of an HDAC3 corepressor complex in mice. Mol. Endocrinol. 26 (2012), 1980–1990.
41. Laffitte, B.A., Chao, L.C., Li, J., Walczak, R., Hummasti, S., Joseph, S.B., Castrillo, A., Wilpitz, D.C., Mangelsdorf, D.J., Collins, J.L., Saez, E., Tontonoz, P., Activation of liver X receptor improves glucose tolerance through coordinate regulation of glucose metabolism in liver and adipose tissue. Proc. Natl. Acad. Sci. U. S. A. 100 (2003), 5419–5424.
42. Caldas, Y.A., Giral, H., Cortazar, M.A., Sutherland, E., Okamura, K., Blaine, J., Sorribas, V., Koepsell, H., Levi, M., Liver X receptor-activating ligands modulate renal and intestinal sodium-phosphate transporters. Kidney Int. 80 (2011), 535–544.
43. Caldas, Y., Giral, H., Sorribas, V., Levi, M., Nuclear receptor LXR: a new partner for sodium-dependent phosphate cotransporters. Contrib. Nephrol. 180 (2013), 64–73.
44. Lee, H.Y., Gao, X., Barrasa, M.I., Li, H., Elmes, R.R., Peters, L.L., Lodish, H.F., PPAR-alpha and glucocorticoid receptor synergize to promote erythroid progenitor self-renewal. Nature 522 (2015), 474–477.
45. Rakhshandehroo, M., Hooiveld, G., Muller, M., Kersten, S., Comparative analysis of gene regulation by the transcription factor PPARalpha between mouse and human. PLoS One, 4, 2009, e6796.
46. Moffit, J.S., Koza-Taylor, P.H., Holland, R.D., Thibodeau, M.S., Beger, R.D., Lawton, M.P., Manautou, J.E., Differential gene expression in mouse liver associated with the hepatoprotective effect of clofibrate. Toxicol. Appl. Pharmacol. 222 (2007), 169–179.
47. Barclay, T.B., Peters, J.M., Sewer, M.B., Ferrari, L., Gonzalez, F.J., Morgan, E.T., Modulation of cytochrome P-450 gene expression in endotoxemic mice is tissue specific and peroxisome proliferator-activated receptor-alpha dependent. J. Pharmacol. Exp. Ther. 290 (1999), 1250–1257.
48. Fan, L.Q., You, L., Brown-Borg, H., Brown, S., Edwards, R.J., Corton, J.C., Regulation of phase I and phase II steroid metabolism enzymes by PPAR alpha activators. Toxicology 204 (2004), 109–121.
49. Patel, R., Bookout, A.L., Magomedova, L., Owen, B.M., Consiglio, G.P., Shimizu, M., Zhang, Y., Mangelsdorf, D.J., Kliewer, S.A., Cummins, C.L., Glucocorticoids regulate the metabolic hormone FGF21 in a feed-forward loop. Mol. Endocrinol. 29 (2015), 213–223.
50. Xu, J., Lloyd, D.J., Hale, C., Stanislaus, S., Chen, M., Sivits, G., Vonderfecht, S., Hecht, R., Li, Y.S., Lindberg, R.A., Chen, J.L., Jung, D.Y., Zhang, Z., Ko, H.J., Kim, J.K., Veniant, M.M., Fibroblast growth factor 21 reverses hepatic steatosis, increases energy expenditure, and improves insulin sensitivity in diet-induced obese mice. Diabetes 58 (2009), 250–259.
51. Zhang, J., Gupte, J., Gong, Y., Weiszmann, J., Zhang, Y., Lee, K.J., Richards, W.G., Li, Y., Chronic over-expression of fibroblast growth factor 21 increases bile acid biosynthesis by opposing FGF15/19 action. EBioMedicine 15 (2017), 173–183.
52. Chen, M.M., Hale, C., Stanislaus, S., Xu, J., Veniant, M.M., FGF21 acts as a negative regulator of bile acid synthesis. J. Endocrinol. 237 (2018), 139–152.